1-4 of 4
Jaroslaw P. Maciejewski
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

BRCA1 Promoter Methylation Is Linked to Defective Homologous Recombination Repair and Elevated miR-155 to Disrupt Myeloid Differentiation in Myeloid Malignancies

Free
Weijie Poh, Robert L. Dilley, Alison R. Moliterno, Jaroslaw P. Maciejewski, Keith W. Pratz, Michael A. McDevitt, James G. Herman
Journal: Clinical Cancer Research
Clin Cancer Res (2019) 25 (8): 2513–2522.
https://doi.org/10.1158/1078-0432.CCR-18-0179
Published: 15 April 2019
View articletitled, BRCA1 Promoter Methylation Is Linked to Defective Homologous Recombination Repair and Elevated miR-155 to Disrupt Myeloid Differentiation in Myeloid Malignancies
Open the PDF for BRCA1 Promoter Methylation Is Linked to Defective Homologous Recombination Repair and Elevated miR-155 to Disrupt Myeloid Differentiation in Myeloid Malignancies in another window
Includes: Supplementary data
Journal Articles

IDH1/2 Mutations Sensitize Acute Myeloid Leukemia to PARP Inhibition and This Is Reversed by IDH1/2-Mutant Inhibitors

Free
Remco J. Molenaar, Tomas Radivoyevitch, Yasunobu Nagata, Mohammed Khurshed, Bartolomiej Przychodzen, Hideki Makishima, Mingjiang Xu, Fonnet E. Bleeker, Johanna W. Wilmink, Hetty E. Carraway, Sudipto Mukherjee, Mikkael A. Sekeres, Cornelis J.F. van Noorden, Jaroslaw P. Maciejewski
Journal: Clinical Cancer Research
Series: Author Choice
Clin Cancer Res (2018) 24 (7): 1705–1715.
https://doi.org/10.1158/1078-0432.CCR-17-2796
Published: 02 April 2018
View articletitled, IDH1/2 Mutations Sensitize Acute Myeloid Leukemia to PARP Inhibition and This Is Reversed by IDH1/2-Mutant Inhibitors
Open the PDF for IDH1/2 Mutations Sensitize Acute Myeloid Leukemia to PARP Inhibition and This Is Reversed by IDH1/2-Mutant Inhibitors in another window
Includes: Supplementary data
Journal Articles

The NEDD8-Activating Enzyme Inhibitor MLN4924 Disrupts Nucleotide Metabolism and Augments the Efficacy of Cytarabine

Free
Steffan T. Nawrocki, Kevin R. Kelly, Peter G. Smith, Mignon Keaton, Hetty Carraway, Mikkael A. Sekeres, Jaroslaw P. Maciejewski, Jennifer S. Carew
Journal: Clinical Cancer Research
Clin Cancer Res (2015) 21 (2): 439–447.
https://doi.org/10.1158/1078-0432.CCR-14-1960
Published: 14 January 2015
View articletitled, The NEDD8-Activating Enzyme Inhibitor MLN4924 Disrupts Nucleotide Metabolism and Augments the Efficacy of Cytarabine
Open the PDF for The NEDD8-Activating Enzyme Inhibitor MLN4924 Disrupts Nucleotide Metabolism and Augments the Efficacy of Cytarabine in another window
Includes: Supplementary data
Journal Articles

Pathogenesis and Consequences of Uniparental Disomy in Cancer

Free
Hideki Makishima, Jaroslaw P. Maciejewski
Journal: Clinical Cancer Research
Clin Cancer Res (2011) 17 (12): 3913–3923.
https://doi.org/10.1158/1078-0432.CCR-10-2900
Published: 15 June 2011
View articletitled, Pathogenesis and Consequences of Uniparental Disomy in Cancer
Open the PDF for Pathogenesis and Consequences of Uniparental Disomy in Cancer in another window
Includes: Supplementary data